Current Issue

Sponsored
Keywords

Regional Development - Related Content

Wall Street BioBeat: New Study Shows Where to Start Your Start-Up
U.K. Found to Be Most Favorable Location for Nascent One-Product Companies
BioMarket Trends: The Globalization of IVD Companies
Alluring Emerging Markets Include BRIC Countries As Well As Indonesia and Vietnam
Feature Articles: Stockholm-Uppsala Region Ups the Ante
Area Bets Big in Quest for International Renown
BioPerspectives: Partnering Across the Pacific
How a U.S.-Japan partnership can provide pharma potential.
Legal Affairs: Patent Considerations for India and China
What to Know Before Beginning to Target Business Opportunities in These Regions

Poland Invests in Biotech Infrastructure
April 16, 2013
Will it be enough for the industry to succeed?
Stockholm-Uppsala Region Ups the Ante
March 11, 2013
The region bets big in the quest for international renown.
No Passage to India
January 31, 2013
Private investment dearth clouds the future of the subcontinent’s fast-growing biopharma industry.
DuBiotech: The Silicon Valley of Biotechnology
November 28, 2012
The Dubai Biotechnology & Research Park is open for business and aiming to catch the eye of biotech companies.
10 Best U.S. Regions to Secure a Biotech Job
October 23, 2012
GEN shows you where careers are made.

BIOTECHNOLOGY IN SPAIN
- Interview with José María Fernández Sousa-Faro, Ph.D., President of the Spanish Association of Bioenterprises (ASEBIO), and Chairman of the Zeltia Group
(BIO) BANKING IN LUXEMBOURG
- Interview with Robert Hewitt, Ph.D., CEO, Integrated Biobank of Luxembourg, and European Editor, Biopreservation and Biobanking (published by Mary Ann Liebert, Inc.)
CHINA'S CHANGING PHARMACEUTICAL LANDSCAPE
- Interview with Michael Keech, Director, Pharmaceutical and Life Sciences Advisory Services Group, PricewaterhouseCoopers
BIOTECHNOLOGY IN GEORGIA
- Interview with Charles Craig, President of Georgia Bio; Stephen Hill, President, Solvay Pharmaceuticals, Inc.; and Russell Medford, M.D., Ph.D., President and CEO, Atherogenics, Inc.
MAKING NEW YORK CITY A BIO-MECCA
- Lenzie Harcum, Vice President of Business Development in Biosciences at the New York City Economic Development Corporation, and Bill Fair, Managing Director at Alexandria Real Estate Equities